Net Cash Provided by (Used in) Financing Activities of Co-Diagnostics, Inc. from 31 Dec 2016 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Co-Diagnostics, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2016 to 31 Mar 2025.
  • Co-Diagnostics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $354,746.
  • Co-Diagnostics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $103,914.
  • Co-Diagnostics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,363,929, a 90% increase from 2022.
  • Co-Diagnostics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $14,033,996, a 3216% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Co-Diagnostics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $354,746 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2023 $482,196 -$632,197 -421% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $150,001 +$1,020 +0.68% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $148,981 -$17,913,102 -99% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $18,062,083 +$12,158,845 +206% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $5,903,238 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q1 2017 $41,500 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1

Co-Diagnostics, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $103,914 +$1,467,843 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $1,363,929 +$12,670,067 +90% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $14,033,996 -$14,484,394 -3216% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $450,398 -$19,292,285 -98% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $19,742,683 +$13,839,445 +234% 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 $5,903,238 +$4,027,083 +215% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $1,876,155 -$4,060,269 -68% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $5,936,424 +$3,646,984 +159% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $2,289,440 01 Jan 2016 31 Dec 2016 10-K 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.